Chia Tai Tianqing Pharmaceutical - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsChia Tai Tianqing Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Fosaprepitant dimeglumine	Fosaprepitant dimeglumine	2021-03-03		—
Fulvestrant	Fulvestrant	2020-02-07	2034	Breast neoplasms

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

breast neoplasms

,

triple negative breast neoplasms

Eribulin mesylate

breast neoplasms

,

Mycophenolate sodium

chronic kidney failure

healthy volunteers/patients

breast neoplasms

,

triple negative breast neoplasms

healthy volunteers/patients

,

pharmacokinetics

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

systemic scleroderma

,

diffuse scleroderma

,

,

non-alcoholic fatty liver disease

,

,

,

,

acquired immunodeficiency syndrome

,

,

immunologic deficiency syndromes

,

colorectal neoplasms

,

urinary bladder neoplasms

,

,

non-small-cell lung carcinoma

,

pancreatic neoplasms

,

neoplasm metastasis

,

squamous cell carcinoma of head and neck

,

,

squamous cell carcinoma

,

esophageal squamous cell carcinoma

therapeutic equivalency

,

,

,

psychomotor agitation

,

acute intermittent porphyria

,

oral manifestations

,

,

Efbemalenograstim alfa

non-small-cell lung carcinoma

,

,

febrile neutropenia

,

colorectal neoplasms

,

pancreatic neoplasms

,

ovarian neoplasms

,

uterine cervical neoplasms

,

,

breast neoplasms

,

Aglatimagene besadenovec

prostatic hyperplasia

,

,

erectile dysfunction

ovarian neoplasms

,

,

neoplasm metastasis

,

kidney neoplasms

,

,

myeloid leukemia acute

,

hematologic diseases

,

myeloid leukemia

,

myelomonocytic leukemia juvenile

,

,

bone marrow diseases

,

,

colonic neoplasms

,

rectal neoplasms

,

essential thrombocythemia

,

polycythemia vera

,

primary myelofibrosis

,

,

,

,

multiple myeloma

,

plasma cell neoplasms

,

alveolar soft part sarcoma

,

,

,

non-small-cell lung carcinoma

,

triple negative breast neoplasms

,

colorectal neoplasms

,

,

breast neoplasms

,

renal cell carcinoma

,

pancreatic neoplasms

,

hepatocellular carcinoma

,

,

liver neoplasms

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

,

esophageal squamous cell carcinoma

,

squamous cell neoplasms

,

pancreatic ductal carcinoma

,

myelodysplastic syndromes

,

myelomonocytic leukemia chronic

,

ovarian epithelial carcinoma

,

gastrointestinal stromal tumors

,

,

,

small cell lung carcinoma

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

prostatic neoplasms

,

large b-cell lymphoma diffuse

,

neuroendocrine tumors

,

urologic neoplasms

,

thyroid neoplasms

,

esophageal neoplasms

,

uterine cervical neoplasms

,

cholangiocarcinoma

,

unknown primary neoplasms

,

adenocarcinoma of lung

,

clear cell adenocarcinoma

,

,

,

uveal neoplasms

,

adenomyoepithelioma

,

,

hematologic neoplasms

,

castration-resistant prostatic neoplasms

,

b-cell lymphoma

,

head and neck neoplasms

,

non-hodgkin lymphoma

,

neuroendocrine carcinoma

,

endometrial neoplasms

,

anaplastic thyroid carcinoma

,

,

non-hodgkin lymphoma

,

follicular lymphoma

,

large b-cell lymphoma diffuse

,

,

myeloid leukemia acute

,

myeloid leukemia

,

,

myelodysplastic syndromes

,

myeloproliferative disorders

,

biphenotypic leukemia acute

,

,

,

t-cell lymphoma

,

t-cell lymphoma peripheral

,

urinary bladder neoplasms

,

neoplasm metastasis

,

pulmonary tuberculosis

,

,

,

community-acquired pneumonia

,

chronic bronchitis

,

,

,

,

bacterial pneumonia

,

community-acquired infections

1

2

3

4

5

6

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use